First GM pigs for allergies. Could xenotransplants be next?

Elie Dolgin • April 12, 2021

The FDA greenlights α-Gal allergy-safe meat, but its makers have organs for transplants in their sights.

The first genetically engineered pig products could soon be coming to a dinner plate—or pharmacy—near you. Late last year, the US Food and Drug Administration (FDA) authorized a facility in northern Iowa to raise hogs that lack the gene needed to produce galactose-α-1,3-galactose (α-Gal), a sugar molecule found naturally on the surface of porcine cells.


Trademarked under the name ‘GalSafe’, the pigs could now provide a source of meat for people who develop tick bite–induced allergic reactions to the sugar, a condition known as α-Gal syndrome. Byproducts of pork production could also be harvested to make allergy-free pharmaceuticals and medical implants. The porcine tissue could help overcome deficiencies in the donor supply of skin and nerve grafts.


Continue reading at Nature Biotechnology.

Girl jumping with arms bandaged
By Elie Dolgin August 27, 2025
Fresh treatments shift the focus from symptom management to repair.
By Elie Dolgin August 27, 2025
Smart algorithms take aim at antimicrobial resistance.